4//SEC Filing
Gallagher Neil 4
Accession 0001562180-23-003520
CIK 0001395937other
Filed
Apr 11, 8:00 PM ET
Accepted
Apr 12, 4:02 PM ET
Size
5.7 KB
Accession
0001562180-23-003520
Insider Transaction Report
Form 4
Gallagher Neil
President, Head of R&D
Transactions
- Award
Stock Options (Right to buy)
2023-04-10$19.35/sh+250,000$4,837,500→ 250,000 totalExercise: $19.35Exp: 2033-04-10→ Common Stock (250,000 underlying)
Footnotes (1)
- [F1]Twenty five percent (25%) of the total number of shares underlying the option shall vest on April 10, 2024, and one-thirty-sixth (1/36th) of the remaining shares underlying the option shall vest monthly thereafter on the last day of each month, subject to the reporting person's continuous service on the relevant vesting dates.
Documents
Issuer
Syndax Pharmaceuticals Inc
CIK 0001395937
Entity typeother
Related Parties
1- filerCIK 0001972849
Filing Metadata
- Form type
- 4
- Filed
- Apr 11, 8:00 PM ET
- Accepted
- Apr 12, 4:02 PM ET
- Size
- 5.7 KB